Directional and Strain-Specific Interaction Between Lactobacillus plantarum and Staphylococcus aureus

Sandeep Kondakala1, Sunghyun Yoon1, Soumana Daddy Gaoh1

  • 1Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.

Microorganisms
|January 8, 2025
PubMed

Insights

Lactobacillus plantarum significantly impacts Staphylococcus aureus, altering protein expression in co-cultures. This proteomic study reveals strain-specific interactions crucial for developing non-antibiotic strategies against S. aureus infections.

Area of Science:

  • Microbiology
  • Proteomics
  • Bacterial Interactions

Background:

  • Staphylococcus aureus causes infections, including toxic shock syndrome.
  • Lactobacillus species can inhibit S. aureus through organic acids and bacteriocins.
  • Molecular mechanisms of Lactobacillus-S. aureus interactions require further investigation.

Purpose of the Study:

  • To analyze the proteomic interactions between Lactobacillus plantarum and Staphylococcus aureus strains.
  • To understand the molecular dynamics of bacterial antagonism in co-culture.
  • To identify strain-specific responses during co-cultivation.

Main Methods:

  • Co-cultivation of Lactobacillus plantarum WCFS1 with Staphylococcus aureus strains FRI-1169 and MN8.
  • Proteomic analysis of differentially expressed proteins (DEPs) in spent media and cytosols.
  • Comparison of protein expression profiles to identify bacterial responses.

Main Results:

  • L. plantarum exhibited a more significant effect on S. aureus, with more DEPs and upregulated proteins.
  • S. aureus showed fewer DEPs and predominantly downregulated proteins in response to L. plantarum.
  • Distinct, directional, and strain-specific proteomic responses were observed.

Conclusions:

  • L. plantarum exerts a strong antagonistic effect on S. aureus at the proteomic level.
  • Proteomic analysis is a valuable tool for elucidating complex bacterial interactions.
  • Findings support the development of non-antibiotic strategies targeting S. aureus infections.